Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-25

FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)

View source ↗

Summary

The FDA approved a supplemental application for Fluoxetine from Dr. Reddy's Laboratories Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE)